During a roundtable event, Amit R. Mehta, MD, and participants discussed treatment selection for a patient with immune thrombocytopenia whose quality of life is impaired even as her platelet count recovers.
|Videos|January 28, 2020
Clinical Cases in Chronic Lymphocytic Leukemia
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Pembrolizumab Biosimilar Candidate FYB206
2
ESMO 2026 Preview: Late-Breaking Studies to Watch Across Tumor Types
3
Durability of PFS and OS Benefit vs. Historical Control
4
FDA Grants Breakthrough Status to Multi-Cancer Early Detection Blood Test
5